Experic expands manufacturing capabilities with TFF Pharmaceuticals

By The Science Advisory Board staff writers

October 26, 2020 -- TFF Pharmaceuticals has expanded its relationship with Experic, a contract manufacturing organization, to install a thin-film freezing (TFF) processing line at Experic's current good manufacturing practice (cGMP) facility in Cranbury, NJ.

Installation of the equipment is expected to be completed in 2021. The site will be the third cGMP manufacturing location containing TFF technology. The TFF platform is designed to improve the solubility and absorption of poor water-soluble drugs and is suited to generate drug powder particles with properties targeted for inhalation delivery, according to the firm.

Experic specializes in dosing and packaging formats, including capsule filling, powder and pellet dosing, and autoinjectors and pen assemblies.

Union Therapeutics licenses COVID-19 tech from TFF
Union Therapeutics has completed an agreement with TFF Pharmaceuticals to obtain a worldwide exclusive license for the use of its thin film freezing technology...

Copyright © 2020 scienceboard.net

International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter